FOXA vs VIR · P/E 14, $24.50B cap vs rev $74.2M
Fox Corp Class A (FOXA) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
FOXA does not have a complete income-statement cache yet.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
FOXA currently screens at market cap $24.50B and trailing P/E 14.1. VIR currently screens at market cap $1.45B.
Not investment advice. Open the FOXA and VIR stock pages for the full models.
Not investment advice.